ArdorComm Media Group

Tuesday, July 21, 2026 8:32 PM

News

Novartis India Launches Pluvicto, Bringing Advanced Precision Therapy for Prostate Cancer Patients

ArdorComm Media News Network

Novartis India has announced the launch of Pluvicto, India’s first regulatory-approved radioligand therapy designed for eligible patients suffering from PSMA-positive metastatic prostate cancer, marking a significant advancement in precision oncology treatment in the country. The newly introduced therapy, Pluvicto (lutetium-177Lu